Following on from our recent post announcing Sleepio's FDA clearance in the US, we are excited to share that DaylightRx has also received FDA clearance, making it the first FDA-cleared digital treatment for generalised anxiety disorder. Our CEO, Yael Berman says, "For too long, patients seeking non-drug treatment options for anxiety have had limited choices. Now, with our FDA-cleared treatment, we're offering a powerful alternative with remission rates of over 70 percent. With this clearance, there is now an accessible non-medication option that patients can trust". Learn more: https://lnkd.in/gPRjmfye
We’re excited to share more big news.. DaylightRx has received FDA clearance! 🎉 The US Food and Drug Administration has granted clearance for DaylightRx, our digital treatment for generalized anxiety disorder. This milestone comes just weeks after the FDA granted clearance for SleepioRx, our digital treatment for insomnia. There have been limited options for patients seeking non-drug treatments for anxiety for far too long, so we’re thrilled to be able to offer an FDA-cleared digital treatment that is safe and effective with a remission rate of over 70%. Full press release: https://lnkd.in/gPRjmfye Read more about the impact of this latest clearance: https://lnkd.in/gj-em9gf #anxiety #digitaltherapeutics #digitaltreatments